BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 14709374)

  • 1. Increased circulating malondialdehyde-modified LDL in the patients with familial combined hyperlipidemia and its relation with the hepatic lipase activity.
    Yamazaki K; Bujo H; Taira K; Itou N; Shibasaki M; Takahashi K; Saito Y
    Atherosclerosis; 2004 Jan; 172(1):181-7. PubMed ID: 14709374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased circulating malondialdehyde-modified LDL levels in patients with coronary artery diseases and their association with peak sizes of LDL particles.
    Tanaga K; Bujo H; Inoue M; Mikami K; Kotani K; Takahashi K; Kanno T; Saito Y
    Arterioscler Thromb Vasc Biol; 2002 Apr; 22(4):662-6. PubMed ID: 11950707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating oxidized low-density lipoprotein and its association with carotid intima-media thickness in asymptomatic members of familial combined hyperlipidemia families.
    Liu ML; Ylitalo K; Salonen R; Salonen JT; Taskinen MR
    Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):1492-7. PubMed ID: 15205217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apolipoprotein, low density lipoprotein subfraction, and insulin associations with familial combined hyperlipidemia. Study of Utah patients with familial dyslipidemic hypertension.
    Hunt SC; Wu LL; Hopkins PN; Stults BM; Kuida H; Ramirez ME; Lalouel JM; Williams RR
    Arteriosclerosis; 1989; 9(3):335-44. PubMed ID: 2497719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contribution of the hepatic lipase gene to the atherogenic lipoprotein phenotype in familial combined hyperlipidemia.
    Allayee H; Dominguez KM; Aouizerat BE; Krauss RM; Rotter JI; Lu J; Cantor RM; de Bruin TW; Lusis AJ
    J Lipid Res; 2000 Feb; 41(2):245-52. PubMed ID: 10681408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between carotid intima-media thickness and low-density lipoprotein size and susceptibility of low-density lipoprotein to oxidation in asymptomatic members of familial combined hyperlipidemia families.
    Liu ML; Ylitalo K; Nuotio I; Salonen R; Salonen JT; Taskinen MR
    Stroke; 2002 May; 33(5):1255-60. PubMed ID: 11988600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LDL particle size in familial combined hyperlipidemia: effects of serum lipids, lipoprotein-modifying enzymes, and lipid transfer proteins.
    Vakkilainen J; Jauhiainen M; Ylitalo K; Nuotio IO; Viikari JS; Ehnholm C; Taskinen MR
    J Lipid Res; 2002 Apr; 43(4):598-603. PubMed ID: 11907142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased intima-media thickness in familial combined hyperlipidemia associated with apolipoprotein B.
    Keulen ET; Kruijshoop M; Schaper NC; Hoeks AP; de Bruin TW
    Arterioscler Thromb Vasc Biol; 2002 Feb; 22(2):283-8. PubMed ID: 11834529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of early atherosclerosis using the ultrasound parameter of the intima-media thickness of the common carotid artery in families with familial combined hyperlipidemia.
    Halenka M; Vaverkova H; Hutyra M; Karasek D; Slavik L; Novotny D; Krskova M
    Int Angiol; 2004 Sep; 23(3):230-7. PubMed ID: 15765037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Common hepatic lipase gene promoter variant determines clinical response to intensive lipid-lowering treatment.
    Zambon A; Deeb SS; Brown BG; Hokanson JE; Brunzell JD
    Circulation; 2001 Feb; 103(6):792-8. PubMed ID: 11171785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Small, dense LDL and elevated apolipoprotein B are the common characteristics for the three major lipid phenotypes of familial combined hyperlipidemia.
    Ayyobi AF; McGladdery SH; McNeely MJ; Austin MA; Motulsky AG; Brunzell JD
    Arterioscler Thromb Vasc Biol; 2003 Jul; 23(7):1289-94. PubMed ID: 12750118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma proprotein convertase subtilisin kexin type 9 levels are related to markers of cholesterol synthesis in familial combined hyperlipidemia.
    Brouwers MC; Konrad RJ; van Himbergen TM; Isaacs A; Otokozawa S; Troutt JS; Schaefer EJ; van Greevenbroek MM; Stalenhoef AF; de Graaf J
    Nutr Metab Cardiovasc Dis; 2013 Nov; 23(11):1115-21. PubMed ID: 23333725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of hormone replacement therapy and hepatic lipase polymorphism on serum lipid profiles in postmenopausal Japanese women.
    Somekawa Y; Umeki H; Kobayashi K; Tomura S; Aso T; Hamaguchi H
    J Clin Endocrinol Metab; 2002 Oct; 87(10):4766-70. PubMed ID: 12364471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determinants of low HDL levels in familial combined hyperlipidemia.
    Soro A; Jauhiainen M; Ehnholm C; Taskinen MR
    J Lipid Res; 2003 Aug; 44(8):1536-44. PubMed ID: 12777471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Common variants in the promoter of the hepatic lipase gene are associated with lower levels of hepatic lipase activity, buoyant LDL, and higher HDL2 cholesterol.
    Zambon A; Deeb SS; Hokanson JE; Brown BG; Brunzell JD
    Arterioscler Thromb Vasc Biol; 1998 Nov; 18(11):1723-9. PubMed ID: 9812910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single LDL apheresis improves serum remnant-like particle-cholesterol, C-reactive protein, and malondialdehyde-modified-low-density lipoprotein concentrations in Japanese hypercholesterolemic subjects.
    Kobayashi J; Katsube S; Shimoda M; Furuhashi K; Kitano S; Masuda M; Maruyama T; Shinomiya M
    Clin Chim Acta; 2002 Jul; 321(1-2):107-12. PubMed ID: 12031599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Higher values of hepatic lipase activity in postmenopause: relationship with atherogenic intermediate density and low density lipoproteins.
    Berg GA; Siseles N; González AI; Ortiz OC; Tempone A; Wikinski RW
    Menopause; 2001; 8(1):51-7. PubMed ID: 11201516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Smaller low-density lipoprotein size as a possible risk factor for the prevalence of coronary artery diseases in haemodialysis patients: associations of cholesteryl ester transfer protein and the hepatic lipase gene polymorphism with low-density lipoprotein size.
    Kimura H; Miyazaki R; Imura T; Masunaga S; Shimada A; Mikami D; Kasuno K; Takahashi N; Hirano T; Yoshida H
    Nephrology (Carlton); 2011 Aug; 16(6):558-66. PubMed ID: 21352420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative assessment of LDL-C and VLDL-C estimation in familial combined hyperlipidemia using Sampson's, Martin's and Friedewald's equations.
    Vargas-Vázquez A; Bello-Chavolla OY; Antonio-Villa NE; Mehta R; Cruz-Bautista I; Aguilar-Salinas CA
    Lipids Health Dis; 2021 May; 20(1):46. PubMed ID: 33952259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carotid artery intima-media thickness in Finnish families with familial combined hyperlipidemia.
    Ylitalo K; Syvänne M; Salonen R; Nuotio I; Taskinen MR; Salonen JT
    Atherosclerosis; 2002 May; 162(1):171-8. PubMed ID: 11947911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.